BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1541022)

  • 1. Over- and underestimation of monoclonal gammopathies by quantification of kappa- and lambda-containing immunoglobulins in serum.
    Bush D; Keren DF
    Clin Chem; 1992 Feb; 38(2):315-6. PubMed ID: 1541022
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.
    Singh G
    Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
    Cao F; Zhang R; Xu L; Liu M; Yuan Y
    Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved monitoring of differences in serial laboratory results.
    Fraser CG
    Clin Chem; 2011 Dec; 57(12):1635-7. PubMed ID: 21976551
    [No Abstract]   [Full Text] [Related]  

  • 6. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
    Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
    Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
    Hill PG; Forsyth JM; Rai B; Mayne S
    Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
    Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
    Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and kappa/lambda quantification.
    Keren DF; Warren JS; Lowe JB
    Clin Chem; 1988 Nov; 34(11):2196-201. PubMed ID: 3141081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.
    Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A
    Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
    Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
    Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
    [No Abstract]   [Full Text] [Related]  

  • 13. Index of light kappa/lambda and lambda/kappa chains in monoclonal gammopathies.
    Tichý M; Hrncír Z
    Neoplasma; 1990; 37(1):55-9. PubMed ID: 2108394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G kappa [IgG kappa] and IgG lambda paraproteinemia in a child with AIDS and response to highly active antiretroviral therapy.
    Seeborg FO; Gay H; Schmiege LM; Bernard D; Shearer WT
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1331-3. PubMed ID: 16275950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulin free light chains in patients with monoclonal gammapathies.
    Lubimova NV; Turko TA; Votyakova OM; Kushlinskii NE
    Bull Exp Biol Med; 2012 Jun; 153(2):249-54. PubMed ID: 22816095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of serum reference intervals for free light chains in a local South African population.
    Zemlin AE; Rensburg MA; Ipp H; Germishuys JJ; Erasmus RT
    J Clin Pathol; 2013 Nov; 66(11):992-5. PubMed ID: 23801498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of the serum kappa/lambda light-chain ratio in the detection of M proteins.
    Laine ST; Soppi ET; Mörsky PJ
    Clin Chim Acta; 1992 Apr; 207(1-2):143-9. PubMed ID: 1591862
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and characterization of antimitochondrial autoantibodies in sera of patients with monoclonal gammopathies.
    Gilbrud B; Weiss P; Bakimer R; Shoenfeld Y
    Immunol Lett; 1995 Mar; 45(3):163-6. PubMed ID: 7558168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
    Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
    Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.